Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Cash from Investing Activities: 2018-2025

Historic Cash from Investing Activities for Arcturus Therapeutics Holdings (ARCT) over the last 6 years, with Sep 2025 value amounting to -$181,000.

  • Arcturus Therapeutics Holdings' Cash from Investing Activities fell 126.25% to -$181,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$726,000, marking a year-over-year increase of 52.33%. This contributed to the annual value of -$648,000 for FY2024, which is 77.66% up from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Cash from Investing Activities stood at -$181,000 for Q3 2025, which was down 32.12% from -$137,000 recorded in Q1 2025.
  • Arcturus Therapeutics Holdings' 5-year Cash from Investing Activities high stood at $378,000 for Q2 2022, and its period low was -$3.8 million during Q4 2022.
  • Over the past 3 years, Arcturus Therapeutics Holdings' median Cash from Investing Activities value was -$328,000 (recorded in 2024), while the average stood at -$429,667.
  • Data for Arcturus Therapeutics Holdings' Cash from Investing Activities shows a peak YoY increase of 193.56% (in 2022) and a maximum YoY decrease of 1,688.98% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Arcturus Therapeutics Holdings' Cash from Investing Activities stood at -$1.1 million in 2021, then tumbled by 240.52% to -$3.8 million in 2022, then surged by 77.02% to -$875,000 in 2023, then skyrocketed by 91.85% to -$80,000 in 2024, then tumbled by 126.25% to -$181,000 in 2025.
  • Its Cash from Investing Activities stands at -$181,000 for Q3 2025, versus -$137,000 for Q1 2025 and -$80,000 for Q3 2024.